Aflac (AFL) Reaches $84.94 After 6.00% Down Move; Morgan Stanley Emerging Markets Debt Fund (MSD)’s Sentiment Is 1.08

January 14, 2018 - By Adrian Erickson

The stock of Aflac Incorporated (NYSE:AFL) is a huge mover today! The stock decreased 7.36% or $6.75 during the last trading session, reaching $84.94. About 13.79M shares traded or 690.17% up from the average. Aflac Incorporated (NYSE:AFL) has risen 7.68% since January 14, 2017 and is uptrending. It has underperformed by 9.02% the S&P500.The move comes after 8 months negative chart setup for the $33.39 billion company. It was reported on Jan, 14 by Barchart.com. We have $79.84 PT which if reached, will make NYSE:AFL worth $2.00B less.

The stock decreased 0.80% or $0.08 during the last trading session, reaching $9.88. About 103,786 shares traded or 87.77% up from the average. Morgan Stanley Emerging Markets (MSD) has risen 8.34% since January 14, 2017 and is uptrending. It has underperformed by 8.36% the S&P500.

Saba Capital Management L.P. holds 1.69% of its portfolio in Morgan Stanley Emerging Markets for 1.66 million shares. Rivernorth Capital Management Llc owns 644,750 shares or 0.53% of their US portfolio. Moreover, Aviance Capital Partners Llc has 0.16% invested in the company for 47,920 shares. The Washington-based Coldstream Capital Management Inc has invested 0.14% in the stock. Sit Investment Associates Inc, a Minnesota-based fund reported 401,793 shares.

Among 17 analysts covering Aflac Incorporated (NYSE:AFL), 1 have Buy rating, 4 Sell and 12 Hold. Therefore 6% are positive. Aflac Incorporated had 47 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Morgan Stanley given on Monday, November 13. Macquarie Research upgraded the stock to “Outperform” rating in Thursday, April 14 report. The rating was maintained by Deutsche Bank with “Hold” on Monday, December 5. The stock of Aflac Incorporated (NYSE:AFL) has “Sell” rating given on Monday, July 10 by RBC Capital Markets. The rating was upgraded by Bruyette & Woods;KBW; KBW” to “Mkt Perform” on Thursday, August 27. The firm has “Hold” rating by Wells Fargo given on Tuesday, January 9. Raymond James maintained Aflac Incorporated (NYSE:AFL) rating on Wednesday, April 19. Raymond James has “” rating and $80 target. The firm has “Mkt Perform” rating by Keefe Bruyette & Woods given on Friday, May 20. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Thursday, December 21 report. Credit Suisse initiated the stock with “Underperform” rating in Friday, October 7 report.

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. The company has market cap of $33.39 billion. It operates through two divisions, Aflac Japan and Aflac U.S. It has a 12.34 P/E ratio. The Aflac Japan segment offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Since August 4, 2017, it had 0 buys, and 6 insider sales for $2.69 million activity. Shares for $2.10 million were sold by CLONINGER KRISS III. $125,363 worth of Aflac Incorporated (NYSE:AFL) was sold by JOHNSON DOUGLAS WAYNE. 310 shares were sold by TILLMAN AUDREY B, worth $25,907 on Thursday, October 26. $107,132 worth of Aflac Incorporated (NYSE:AFL) was sold by HUDSON ELIZABETH J on Thursday, September 21. Another trade for 620 shares valued at $50,525 was made by Daniels James Todd on Friday, September 29.

Analysts await Aflac Incorporated (NYSE:AFL) to report earnings on January, 30. They expect $1.55 EPS, up 0.65% or $0.01 from last year’s $1.54 per share. AFL’s profit will be $609.38 million for 13.70 P/E if the $1.55 EPS becomes a reality. After $1.70 actual EPS reported by Aflac Incorporated for the previous quarter, Wall Street now forecasts -8.82% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: